Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: November 2008
HMG-CoA Reductase Inhibitors and muscular disorders
01 November 2008 | Irish Medicines Board
(atorvastatin; fluvastatin ; pravastatin ; rosuvastatin; simvastatin) HMG-CoA reductase inhibitors, commonly known as ‘statins’ are a class of medicines authorised as an adjunct to diet for the treatment of hypercholesterolaemia, when the response to diet and other non-pharmacological treatments (e.g.... Read more
Lexapro compared with duloxetine
escitalopram, SSRI, Lundbeck, Lexapro | 01 November 2008 | New Clinical Evidence
Lexapro offers greater efficacy and tolerability compared with duloxetine in the treatment of major depressive disorder (1)... Read more
Once-yearly Aclasta new approval
01 November 2008 | New Clinical Evidence
Once-yearly Aclasta approved in EU to treat osteoporosis in men and to reduce risk of new fractures following hip fracture both in men and postmenopausal women.... Read more
Acerycal
01 November 2008 | New Products
Company: Servier Laboratories (Ireland) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredients: Perindopril arginine / amlodipine, 5mg/5mg, 5mg/10mg, 10mg/5mg and 10mg/10mg. Description: White tablets engraved with strength on 1 side and Servier logo on the other. 5/5mg, rod-shaped; 5/10mg,... Read more
Intelence
01 November 2008 | New Products
Company: Janssen-Cilag Ltd. Legal category: Hospital. GMS. Sport permitted. Active ingredient: Etravirine 100mg. Description: White to off-white, oval tablet, debossed with T125 on one side and 100 on the other. Presentation: 120, €465 Indications: Treatment of HIV-1 infection in antiretroviral... Read more
Pradaxa
01 November 2008 | New Products
Company: Boerhinger Ingelheim Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Dabigatran etexilate (as mesilate), 75mg, 110mg. Description: Light blue and cream capsules filled with yellowish pellets, imprinted with company symbol and R75 and R110 respectively. Presentation: 75mg-10,... Read more
Relistor
01 November 2008 | New Products
Wyeth Pharmaceuticals Ltd is pleased to advise you that Relistor 12mg/0.6ml solution for injection is now available. Relistor (methylnaltrexone bromide) is indicated for the treatment of opioid-induced constipation in advanced illness patients who are receiving palliative care when response to... Read more
Risperger
01 November 2008 | New Products
Company: Gerard Laboratories. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Risperidone 0.5mg, 1mg, 2mg, 3mg. Description: Respectively reddish-brown, white, orange and yellow circular biconvex film-coated tablet with break-line. Presentation: 0.5mg-20, €9.45; 1mg-20, €12.38; 2mg-60, €73.20; 3mg-60, €107.00. Indications: Treatment... Read more
Thalidomide Pharmion
01 November 2008 | New Products
Company: Celgene UK and Ireland Ltd. Legal category: Prescription. HT. Sport permitted. Active ingredient: Thalidomide 50mg. Description: White opaque hard capsules marked Thalidomide 50mg Pharmion. Presentation: 28, €336. Indications: In combination with melphalan and prednisone as first line treatment of... Read more
Xarelto
01 November 2008 | New Products
Company: Bayer Schering Pharma. Legal category: Prescription. GMS from 01/12/08. Sport permitted Active ingredient: Rivaroxaban 10mg. Description: Light red, round film-coated tablets marked with the BAYER-cross on one side and 10 and a triangle on the other side. Presentation: 30;... Read more
Lipaprav 10mg
01 November 2008 | New Presentations
Company: Gerard Laboratories. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pravastatin sodium 10mg. Description: Pink-peach, indented capsule-shape film-coated tablet with 10 on one side. Presentation: 28, €16.10 Indications: Treatment of primary hypercholesterolemia (HC) or mixed dyslipidaemia, as an adjunct... Read more
Amoclav 250/125mg new pack size
01 November 2008 | New this Month
Rowex Ltd are pleased to announce the introduction of a new pack size of Amoclav (amoxicillin/clavulanic) 250/125mg film-coated x 21’s. The price of Amoclave 250/125mg x 21’s is €6.08 and as with the other Amoclav presentations, it is reimbursable through... Read more
Champix 4-Week Starter Pack now available
01 November 2008 | New this Month
Pfizer Healthcare Ireland is pleased to announce the introduction of a 4-Week Starter Pack for Champix which is reimbursed under the PCRS scheme from the 1st of September. Champix is indicated for smoking cessation in adults and should be used... Read more
Recall of Ionsys
01 November 2008 | New this Month
Janssen-Cilag Ltd has voluntarily recalled Ionsys, as a precaution, following a suspected product defect of some units in one lot. The defect could potentially result in self activation of the system and an investigation is ongoing to determine the root... Read more
Metronide 400mg discontinuation
01 November 2008 | Discontinued Products
Clonmel Healthcare Ltd wishes to inform you that Metronide 400mg is being discontinued. Metronide 200mg remains on the market.... Read more
